Cost-Benefit Analysis of Haemophilus Influenzae Type B Immunization in Korea
Journal of Korean Medical Science
;
: 176-184, 2008.
Artigo
em Inglês
| WPRIM
| ID: wpr-113721
ABSTRACT
An economic evaluation of Haemophilus influenzae type b (Hib) immunization was conducted to examine whether Hib immunization should be included in the Korea's national immunization program. The costs and benefits included direct and indirect values and an estimation of the economic efficiency. We determined that a universal Hib immunization program in Korea would prevent 17 deaths and 280 invasive Hib cases. When we assumed the one Hib immunization cost as 26,000 won, the national Hib immunization would cost 34.6 billion won. Costs for various Hib diseases were estimated at 26.8 billion won (11.8 billion won from direct costs and 14.9 billion won from indirect costs). A benefit-cost ratio of 0.77 showed that the economic efficiency of the integration of Hib immunization in Korea is low because of the low incidence rate of Hib disease and high price of vaccine. However, if the Hib immunization cost decrease to less than 20,000 won, a benefit-cost ratio increase to 1.0 and above, integrating Hib immunization into the national immunization program with economic efficiency can be considered.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Medicina Estatal
/
Técnicas de Apoio para a Decisão
/
Esquemas de Imunização
/
Imunização
/
Análise Custo-Benefício
/
Efeitos Psicossociais da Doença
/
Vacinas Anti-Haemophilus
/
Modelos Econômicos
/
Haemophilus influenzae tipo b
/
Infecções por Haemophilus
Tipo de estudo:
Avaliação Econômica em Saúde
/
Estudo prognóstico
Limite:
Criança
/
Criança, pré-escolar
/
Humanos
/
Lactente
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Journal of Korean Medical Science
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS